09/29/2025 | Press release | Distributed by Public on 09/29/2025 10:08
Mick Farrell, Resmed Chairman and CEO to deliver opening remarks and contribute his perspective as part of a keynote panel on the future of AI in healthcare.
SAN DIEGO, September 29, 2025 -Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, will feature multiple speakers at the AdvaMed MedTech conference. Mick Farell, Chairman and CEO, will deliver opening remarks and take the stage at the keynote luncheon with fellow industry leaders to discuss how artificial intelligence is transforming patient care and redefining the future of MedTech innovation.
See below details for Mick Farrell's featured sessions at the conference.
Resmed leaders will also participate in sessions covering key industry topics, including medical technology innovation, reimbursement challenges, real-world evidence for health equity, AI in healthcare, and patient-centered care. Additional Resmed speaker sessions are noted below.
Resmed sponsorship highlights:
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We're relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we're redefining sleep health at Resmed.com and follow @Resmed.
For MediaCaela [email protected]@resmed.com
For Investors Salli [email protected]@resmed.com